Aytu BioScience Inc. (AYTU)

[ash111]

Cash burn rate will be decreased sharply (already started) due to high revenues forecast upcoming earnings and beyond. these FDA approved drugs have $3.8m Market potential vs a few millions current Market cap.

it's newest FDA approval product Zolpimist, just been added a month ago hence will be represented in upcoming earning and beyond. see last Paragraph (above) includes market potential:

market potential:


strong Pipeline/ Catalysts:

2019 will be a huge year for this Company per both CEO and analysts. sales and revenues boost (yahoo Finance):

* Sales Growth 2019 by analyst coverage: 255.20%

* Revenue Estimate 2019 $13M
fits CEO's comments recently.

These block baster FDA approved drugs worth a lot more than a few millions market cap, that's for sure. Now can seat down and wait big data in a few weeks and a good chance it will be great like the previous one (and strong pipeline in 2019 too).
I expect a massive upside the coming weeks.